Clinical Trial Update: Safety Study of Chimeric Natriuretic Peptide(CD-NP) in Stable LVAD Patients [Phase 1]

View source ↗

Summary

A Phase 1 safety study of Chimeric Natriuretic Peptide (CD-NP) in stable LVAD patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• CD-NP (CD-NP)

Snippet

Sponsor: Mayo Clinic | Conditions: Left Ventricular Insufficiency | Phase 1 | Status: COMPLETED